https://kiorapharma.reportablenews.com daily 1.0 https://kiorapharma.reportablenews.com/pr/kiora-pharmaceuticals-reports-its-ion-channel-modulator-kio-300-suppressed-seizure-activity-in-preclinical-epilepsy-model 2026-06-18T11:01:00Z monthly 0.5 https://kiorapharma.reportablenews.com/pr/kiora-presents-abacus-data-at-aao 2023-11-04T16:14:00Z monthly 0.5 https://kiorapharma.reportablenews.com/pr/kiora-sharpens-focus-on-orphan-retinal-diseases 2023-10-27T14:41:46Z monthly 0.5 https://kiorapharma.reportablenews.com/pr/let-there-be-light-a-spotlight-on-kiora 2023-08-02T14:28:42Z monthly 0.5 https://kiorapharma.reportablenews.com/pr/biotech-leader-carmine-stengone-joins-kiora-pharmaceuticals-board-of-directors-bolstering-development-of-innovative-eye-disease-treatments 2023-08-01T12:06:12Z monthly 0.5 https://kiorapharma.reportablenews.com/pr/kiora-s-investigational-treatment-for-retinitis-pigmentosa-kio-301-demonstrates-visual-function-restoration-in-patients-who-are-blind 2023-04-27T14:57:04Z monthly 0.5